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Pathogens induce several changes in the host cell signaling and trafficking mechanisms 
in order to evade and manipulate the immune response. One prominent pathogen- 
mediated change is the formation of lipid-rich organelles, termed lipid bodies (LBs) or lipid 
droplets, in the host cell cytoplasm. Protozoan parasites, which contribute expressively 
to the burden of infectious diseases worldwide, are able to induce LB genesis in non- 
immune and immune cells, mainly macrophages, key players in the initial resistance 
to the infection. Under host–parasite interaction, LBs not only accumulate in the host 
cytoplasm but also relocate around and move into parasitophorous vacuoles. There is 
increasing evidence that protozoan parasites may target host-derived LBs either for gain-
ing nutrients or for escaping the host immune response. Newly formed, parasite-induced 
LBs may serve as lipid sources for parasite growth and also produce inflammatory 
mediators that potentially act in the host immune response deactivation. In this mini 
review, we summarize current knowledge on the formation and role of host LBs as sites 
exploited by intracellular protozoan parasites as a strategy to maintain their own survival.
Keywords: infectious diseases, lipid droplets, inflammation, phagocytosis, lipid mediators, parasite survival, 
parasitophorous vacuole
inTRODUCTiOn
Protozoan parasitic infections comprise devastating infectious diseases, such as malaria, visceral 
leishmaniasis, toxoplasmic encephalitis, and trypanosomiasis, which still account for a large propor-
tion of death and disability worldwide (1). Many protozoan parasites have an obligate intracellular 
existence. The infection is initiated when the parasite enter the host target cell and is internalized 
within a plasma membrane-derived vacuole, the parasitophorous vacuole (PV) (2). Within the host, 
protozoan parasites that are mainly intracellular will only cause infectious disease if they are able to 
survive and multiply within the PV (2, 3).
The events of the PV formation and progression generally occur in parallel with accentuated 
genesis of lipid-rich organelles, termed lipid bodies (LBs) or lipid droplets, in the host cell cytoplasm 
[reviewed in Ref. (4, 5)]. It is now well documented that experimental and clinical infections with a 
range of protozoan parasites trigger LB accumulation (Table 1) and an intriguing interaction with 
the PV [reviewed in Ref. (5)]. Other pathogens, such as bacteria and viruses, also induce LB forma-
tion within different cell types, indicating that LB accumulation in response to infectious diseases is 
a broad event and may have implications for microbial pathogenesis (5–8).
FiGURe 1 | Lipid bodies (LBs) accumulate in the host cell cytoplasm 
in response to interaction with protozoan parasites and favor parasite 
survival. Top panel shows an electron micrograph of a heart inflammatory 
macrophage infected with Trypanosoma cruzi. Note the presence of dividing 
amastigotes (A) within the parasitophorous vacuole (outlined in green) and 
the high number of LBs in the cytoplasm. LBs typically appear as round 
electron dense organelles in the cell cytoplasm. A model to explain how 
protozoan parasite-induced LB formation favors parasite growth and 
replication is shown in the bottom panel. Interaction of LBs with the 
parasitophorous vacuole, an event also triggered by the parasite infection, 
leads to discharge of LB contents, such as cholesterol, triacylglycerol (TAG), 
and phosphatidylcholine, which serve as lipid sources for parasite growth. 
Newly formed LBs are also sites for prostaglandin E2 synthesis (PGE2), a 
potent inflammation mediator that potentially inhibit the host Th1 immune 
response, thus decreasing the microbicidal capacity of the parasitophorous 
vacuole. Nu, nucleus. Scale bar, 600 nm. Top panel was reprinted from Ref. 
(27) with permission.
TABLe 1 | Protozoan parasite-induced lipid body formation in host cells.
Parasite Cell type Organism/
model
Reference
Leishmania 
amazonensis
Peritoneal macrophages Mouse (9)
Dendritic leukocytes Mouse (10)
Leishmania major Blood-marrow-derived 
macrophages
Mouse (11, 12)
Plasmodium berghei Hepatocytes Mouse (13)
Renal tubular cells Mouse (14)
Plasmodium chabaudi Hepatocytes Mouse (15)
Toxoplasma gondii Fibroblasts Human (16)
Skeletal muscle cells Mouse (17)
Trypanosoma cruzi Heart macrophages Rat (18, 19)
Peritoneal macrophages Rat (18, 19)
Uterine macrophages Rat (19)
Peritoneal macrophages Mouse (20)
Placental cells Human (21)
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While the successful replication within the PV is under influence 
of several factors, there is increasing evidence that LB organelles 
are important for the rapid intracellular reproduction of protozoan 
parasites (5). Protozoan parasites require large amounts of lipids 
necessary for membrane biogenesis of new progenies [reviewed in 
Ref. (22, 23)] and may take advantage of these organelles as high-
energy substrate sources. LBs within infected cells are also able 
to produce inflammatory mediators that potentially can inhibit 
the host Th1response, thus, favoring parasite growth [reviewed in 
Ref. (4)]. In this mini review, we will discuss the role of host LBs 
as organelles modulated by intracellular protozoan parasites for 
survival.
LB STRUCTURe AnD viSUALiZATiOn
Lipid bodies are common organelles distributed in the cyto-
plasm of prokaryotic and eukaryotic cells (5). As a general 
feature, LBs contain a core rich in neutral lipids, surrounded 
by a monolayer of phospholipids with structural proteins  –   
the perilipin (PLIN) family proteins (5). Proteins are not 
restricted to the LB surface. It is documented that many types 
of proteins are present in the LB internum depending on the 
cell type (24–26).
In spite of variations in the LB composition, these organelles 
are seen in the cell cytoplasm as compartmentalized round sites 
by light microscopy or transmission electron microscopy (TEM). 
While LB imaging under light microscopy usually requires the 
use of specific lipid probes, ultrastructural observation does not 
need any additional labeling because LBs lack a true delimiting 
unit membrane structure, which enables unambiguous identifi-
cation by TEM (Figure 1) (4, 8, 26).
PROTOZOAn PARASiTeS inDUCe LB 
ACCUMULATiOn in HOST CeLLS
Several protozoan parasites induce LB formation in a variety of host 
immune and non-immune cells (Table 1). Under host–parasite 
interaction, LBs not only accumulate but also increase in size and 
undergo ultrastructural changes in the host cell cytoplasm. These 
structural modifications of LBs have been well demonstrated 
during in vitro and in vivo studies with Trypanosoma cruzi, the 
causal agent of Chagas’ disease (18, 19). This pathology elicits a 
strong inflammatory response characterized by elevated infiltra-
tion of macrophages in the target organs, mainly the heart (28). 
Histopathological studies conducted during the acute phase 
of this disease showed that increased myocardial parasitism is 
paralleled by increased size of LBs within inflammatory mac-
rophages in which LBs can reach up to 4 μm in diameter (19). 
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Moreover, LBs show varied electron-density in response to the 
T. cruzi infection, a morphological change likely associated with 
mobilization and/or in situ synthesis of lipid mediators [reviewed 
in Ref. (8)]. The capability of host LBs to generate these com-
pounds will be discussed later.
Increase of LB size in parallel with augmented number of 
these organelles was also found in dendritic leukocytes host-
ing live Leishmania amazonensis amastigotes (10). Overall, as 
noted in diverse cell types (Table 1), it is clear that protozoan 
parasites are able to trigger LB formation in host cells. But how 
is the mechanism leading to LB genesis? Similar to other stud-
ies with mycobacteria (29, 30), it has been demonstrated that 
parasite uptake potentiates LB formation within host cells but 
is not essential for triggering this event. After 24 h of infection 
with T. cruzi, peritoneal macrophages with internalized para-
sites as well as non-parasitized cells show increased number 
of LBs compared to control, non-infected cells, suggesting a 
bystander amplification of the cell response (20). Accordingly, 
inhibition of parasite phagocytosis did not abolish LB genesis 
during infection with Leishmania major (11). These authors 
have recently showed that while phagocytosis of latex beads by 
macrophages did not trigger LB formation, this phenomenon 
is equally induced by both live and heat-killed parasites (11). 
Altogether, these results imply that soluble factors in parasitized 
cells may act in a paracrine manner to produce LB in non-
parasitized bystander cells (11). While LB formation occurs 
through a toll-like receptor-2 (TLR2)-dependent mechanism 
as documented during T. cruzi infection in macrophages 
(20), the identification of downstream signaling pathways 
involved in this event during parasitic infections awaits further 
investigation.
newLY FORMeD LBs ARe ReCRUiTeD 
TO THe PROXiMiTY OF PARASiTeS
Interestingly, protozoan parasites trigger a redistribution of the 
newly formed LBs around parasite-containing phagosomes. 
As documented by studies with T. cruzi (18, 19), L. major  
(11, 12), L. amazonensis (10), and Toxoplasma gondii (17, 31), LBs 
accumulate in close proximity to PVs or even move into these 
vacuoles, suggesting that these pathogens take advantage of these 
organelles.
Indeed, TEM analyses have enabled the identification of 
intimate contact between LBs and the PV membrane (10, 17–20, 
31, 32). In 2003, our group was the first to observe that during 
an in  vivo experimental infection with a pathogen (T. cruzi), 
LBs were internalized into parasite-containing phagosomes 
(18). Following studies found the same event for infections with 
different species of bacteria [reviewed in Ref. (5)] and with the 
protozoan parasites T. gondii (17) and L. major (11).
How LBs translocate across the phagosome membrane? 
This mechanism has been mainly addressed in studies with 
bacteria. LB-associated proteins, secreted by bacteria seem to 
be involved in capturing LB into bacteria-containing vacuoles, 
while LB translocation seems to involve displacement of the 
LB structural protein PLIN2/adipose differentiation-related 
protein (ADRP), which is constitutively associated with 
the surface of LBs (33). Although studies of membrane sites 
between pathogen-containing compartments and intracellular 
host organelles has been gaining more attention in the literature 
[reviewed in Ref. (34)], the mechanistic details underlying the 
intriguing LB–phagosome interaction remains to be fully 
defined.
HOST LiPiDS, LBs, AnD inTRACeLLULAR 
PARASiTe GROwTH
Lipid metabolic pathways have been demonstrated as major net-
works modulated by protozoan parasites in host cells. Numerous 
studies with T. gondii, malaria parasites (Plasmodium berghei, 
Plasmodium falciparum, and Plasmodium yoelii), L. amazonensis, 
Cryptosporidium parvum, and Eimeria bovis have documented 
that these parasites are able to (i) induce accumulation of lipids, 
such as neutral lipids [triacylglycerol (TAG), diacylglycerol, and 
cholesterol esters], cholesterol, and/or phospholipids, especially 
phosphatidylcholine in host cells (10, 12, 35–37); (ii) acquire 
lipid resources, such as cholesterol and phospholipids from their 
host environment into the PV (16, 36, 38–40), and/or (iii) use 
host lipids to synthesize complex own lipids or even own LBs 
(16, 38, 41).
Thus, although the nutritional requirements of these para-
sites are intricate, overall it is believed that host lipids are central 
to support successful parasite replication within the PV (16, 32, 
37, 38, 42, 43). Host lipid acquisition is also considered cru-
cial to PV maturation. This vacuole undergoes a pronounced 
membranous remodeling associated with formation of an 
internal network of tubules and vesicles as observed during the 
infection with T. gondii (42, 44). By using different approaches, 
including fluorescence recovery after photobleaching (FRAP) 
microscopy, Caffaro and Boothroyd demonstrated that host 
cells are major lipid contributors to the PV remodeling and that 
lipids are transferred in a continuous way from the host into 
the PV (42).
How is the contribution of host LBs as lipid sources for proto-
zoan parasites? Consistent with parasite-induced host LB forma-
tion (Table 1), LB genesis in parallel to host lipid reprograming/
accumulation (10, 12) and host LB–PV interaction (10–12, 
17–19, 31), it is believed that these organelles act as important 
lipid sources for parasite growth.
Several classes of lipids, including neutral lipids, cholesterol, 
and phospholipids, make up LBs (45). Because protozoan para-
sites are not competent or have limited ability to synthesize lipids 
[reviewed in Ref. (22, 46)], LBs could be an essential source of 
both TAG and cholesterol for these parasites (10). These mol-
ecules are important as precursors for membrane neogenesis for 
newly formed parasites [reviewed in Ref. (22, 46)]. Moreover, the 
phospholipid monolayer of LBs consists of numerous phospho-
lipid species of which phosphatidylcholine is the most abundant 
(47). Thus, it is likely that LB-derived lipids are transferred from 
host to the PV and taken up by replicating parasites. Indeed, by 
using a fluorescent probe (BODIPY-phosphatidylcholine) and 
live imaging microscopy, Charron and Sibley showed that this 
4Toledo et al. Lipid Bodies and Protozoan Parasites
Frontiers in Immunology | www.frontiersin.org May 2016 | Volume 7 | Article 174
probe moved from host plasma membrane and/or host LBs, seen 
as dispersed puncta in the host cytoplasm, to LBs formed within 
the parasite (16). However, the potential relocation of other lipids 
from host LBs to the parasite still needs to be better explored in 
future studies.
Does depletion of host lipids and/or LBs impact protozoan 
parasites development within host cells? In T. gondii infection, 
inhibition of cholesterol esterification in the host cell blocks 
parasite growth (38). Exposure to cholesterol esterification 
inhibitors led to reduction of cholesteryl ester synthesis, morpho-
logical changes in parasite LBs, and deformations of the parasite 
plasma membrane with discharge of parasite content into the PV 
(38). Accordingly, the use of inhibitors targeting the host cel-
lular cholesterol de novo synthesis and processing repressed both 
E. bovis proliferation and LB formation within host endothelial 
cells (43). On the other hand, depletion of cholesterol content did 
not impact malaria parasites (P. berghei and P. yoelii) development 
within hepatocytes (39). In this case, the authors consider that 
the parasite may exploit alternative sources in these cells to sustain 
infectivity (39). In fact, protozoan parasites can divert lipids from 
other sources than the intracellular environment. C. parvum, the 
causal agent of cryptosporidiosis, a life-threatening diarrheal 
disease in immunocompromised individuals (48), scavenges cho-
lesterol from plasma low-density protein (LDL) and micelles, and 
to a lesser extent from the cholesterol pathway within enterocytes 
(40). Removal of cholesterol from the media, and to lesser extent 
from host intracellular pools, obstructs parasite reproduction 
(40).
During the experimental infection with T. cruzi, our group 
demonstrated that the use of C75, an inhibitor of fatty acid syn-
thase, led to both inhibition of LB formation and parasite division 
within macrophages (20). While C75 had no direct cytotoxic 
effect on the parasite, intracellular parasite replication was likely 
affected by an accentuated reduction of the LB numbers (around 
66%) after cell treatment with C75 (20).
HOST LBs PRODUCe PGe2 in  
ReSPOnSe TO inFeCTiOn wiTH 
PROTOZOAn PARASiTeS
One interesting aspect of LBs is that they are able to change 
their composition in response to inflammatory events as 
documented in cells from the immune system [reviewed in Ref. 
(49)]. LBs contain stores of arachidonic acid (AA), indicating 
that these organelles are potentially able to initiate cascades 
that culminate in the formation of inflammatory media-
tors (eicosanoids) (50, 51). Eicosanoid-generating enzymes 
(52–55), and in  situ synthesis of eicosanoids (prostaglandins 
and leukotrienes) were indeed documented in these organelles 
within activated leukocytes and other cells from the immune 
system during inflammatory conditions [for example, see Ref. 
(29, 56–58)].
During the infection with T. cruzi (18), T. gondii (17, 31), 
and L. amazonensis (9), significant correlations between LB 
formation and enhanced generation of eicosanoids, specifically 
prostaglandin E2 (PGE2), by host cells have been observed. 
Moreover, T. gondii infection also elicited a time-dependent 
increase of cyclooxygenase-2 (COX-2) mRNA levels, indicating 
that the PGE2 may be a product of an active COX pathway within 
host cells (17).
By investigating the intracellular specific localization of 
both COX-2 and PGE2 within T. cruzi-infected macrophages, 
we found that both molecules were immunolocalized in LBs, 
indicating that LBs act as sources of PGE2 (20). Interestingly, 
cell treatment with non-steroidal anti-inflammatory drugs 
(NSAIDs) inhibited both LB formation and LB-derived PGE2 
synthesis in a mechanism independent of COX inhibition (20), 
as previously documented (59). Therefore, accumulation of 
LBs in infected host cells may modulate the production of an 
innate immune response with production of PGE2, which in 
turn may contribute to a permissive environment for pathogen 
proliferation. For example, during the infection with T. gondii, 
the increased numbers of LBs within macrophages correlated 
with high PGE2 levels, decreased nitric oxide (NO) production 
and parasite survival (31). In fact, high concentrations of PGE2 
potentially inhibit the Th1 response, tumor necrosis factor 
alpha (TNF-α) and/or NO production (60–62). This scenario 
is also detected during infections with mycobacteria (29, 30), 
demonstrating that pathogen-induced LB formation associated 
with PGE2 synthesis is a broader event that can potentially sup-
port intracellular pathogen survival. Taken together, these data 
suggest a model by which LBs are acting as potential stations for 
the survival of protozoan parasites within host cells, as depicted 
in Figure 1.
FinAL ReMARKS AnD FUTURe 
DiReCTiOnS
Several key issues remain to be addressed to better understand 
the link between LBs and parasite survival within host cells 
during infections with intracellular parasitic protozoans. It is 
now clear that host LBs interact with PVs and that the parasite 
has a remarkable ability to sequester host lipids. What are the 
molecular mechanisms involved in LB translocation into the 
PV and how the LB content is extracted by the parasite? In 
patients with chronic mycobacterial infection (Mycobacterium 
leprae), round classical LBs are observed in contact with 
pathogen-containing phagosomes and intact bacteria are seen 
completely enmeshed in accumulated lipid content within 
the vacuole (63). Are LBs important for pathogen survival in 
chronic parasitic infections? Considering that LBs are sources 
for parasite development, could these organelles be target by 
therapeutic treatment? How significant is the contribution 
of host LBs and/or parasite LBs to parasite development? 
Moreover, the mechanisms by which new molecules, includ-
ing natural products, can affect pathways of the parasite lipid 
metabolism and both host and parasite LB formation have yet 
to be fully appreciated.
5Toledo et al. Lipid Bodies and Protozoan Parasites
Frontiers in Immunology | www.frontiersin.org May 2016 | Volume 7 | Article 174
AUTHOR COnTRiBUTiOnS
RM prepared the manuscript. All authors contributed in part to 
writing and editing the manuscript and approved the final version.
ACKnOwLeDGMenTS
We would like to thank present and past members of the Laboratory 
of Cellular Biology (UFJF, Brazil), Centro de Microscopia 
(Univer sidade Federal de Minas Gerais  –  UFMG) and Centro 
de Aquisição e Processamento de Imagens-CAPI (ICB-UFMG) 
for the use of their facilities. We acknowledge Kennedy Bonjour 
for careful assistance with the illustration (Figure 1) used in this 
paper. We apologize to investigators whose relevant work has not 
been cited because of space constraints.
FUnDinG
This work was supported by from Conselho Nacional de 
Desenvolvimento Científico e Tecnológico (CNPq, Brazil-477475/ 
2013-2; 469995/2014-9, 311083/2014-5; 308291-2012-3), Brazilian 
Ministry of Health and Fundação de Amparo a Pesquisa do Estado de 
Minas Gerais (FAPEMIG, Brazil-CBB-APQ-02239-14; CBB-APQ- 
02477-14). DT is a PhD student supported by a CNPq fellowship.
ReFeRenCeS
1. Bar AK, Phukan N, Pinheiro J, Simoes-Barbosa A. The interplay of host micro-
biota and parasitic protozoans at mucosal interfaces: implications for the out-
comes of infections and diseases. PLoS Negl Trop Dis (2015) 9(12):e0004176. 
doi:10.1371/journal.pntd.0004176 
2. Sibley LD. Invasion and intracellular survival by protozoan parasites. Immunol 
Rev (2011) 240(1):72–91. doi:10.1111/j.1600-065X.2010.00990.x 
3. Liévin-Le Moal V, Loiseau PM. Leishmania hijacking of the macrophage 
intracellular compartments. FEBS J (2015) 282(4):598–607. doi:10.1111/
febs.13601 
4. Melo RCN, D’Avila H, Wan HC, Bozza PT, Dvorak AM, Weller PF. Lipid bod-
ies in inflammatory cells: structure, function, and current imaging techniques. 
J Histochem Cytochem (2011) 59(5):540–56. doi:10.1369/0022155411404073 
5. Melo RCN, Dvorak AM. Lipid body-phagosome interaction in macrophages 
during infectious diseases: host defense or pathogen survival strategy? PLoS 
Pathog (2012) 8(7):e1002729. doi:10.1371/journal.ppat.1002729 
6. Saka HA, Valdivia R. Emerging roles for lipid droplets in immunity and 
host-pathogen interactions. Annu Rev Cell Dev Biol (2012) 28:411–37. 
doi:10.1146/annurev-cellbio-092910-153958 
7. Nicolaou G, Goodall AH, Erridge C. Diverse bacteria promote macrophage 
foam cell formation via toll-like receptor-dependent lipid body biosynthesis. 
J Atheroscler Thromb (2012) 19(2):137–48. doi:10.5551/jat.10249 
8. Dias FF, Zarantonello VC, Parreira GG, Chiarini-Garcia H, Melo RCN. 
The intriguing ultrastructure of lipid body organelles within activated 
macrophages. Microsc Microanal (2014) 20(3):869–78. doi:10.1017/
S143192761400066X 
9. Pinheiro RO, Nunes MP, Pinheiro CS, D’Avila H, Bozza PT, Takiya CM, et al. 
Induction of autophagy correlates with increased parasite load of Leishmania 
amazonensis in BALB/c but not C57BL/6 macrophages. Microbes Infect (2009) 
11(2):181–90. doi:10.1016/j.micinf.2008.11.006 
10. Lecoeur H, Giraud E, Prevost MC, Milon G, Lang T. Reprogramming neutral 
lipid metabolism in mouse dendritic leucocytes hosting live Leishmania 
amazonensis amastigotes. PLoS Negl Trop Dis (2013) 7(6):e2276. doi:10.1371/
journal.pntd.0002276 
11. Rabhi S, Rabhi I, Trentin B, Piquemal D, Regnault B, Goyard S, et al. Lipid 
droplet formation, their localization and dynamics during Leishmania major 
macrophage infection. PLoS One (2016) 11(2):e0148640. doi:10.1371/journal.
pone.0148640 
12. Rabhi I, Rabhi S, Ben-Othman R, Rasche A, Daskalaki A, Trentin B, et  al. 
Transcriptomic signature of Leishmania infected mice macrophages: a meta-
bolic point of view. PLoS Negl Trop Dis (2012) 6(8):e1763. doi:10.1371/journal.
pntd.0001763 
13. Rodríguez-Acosta A, Finol HJ, Pulido-Méndez M, Márquez A, Andrade G, 
González N, et  al. Liver ultrastructural pathology in mice infected with 
Plasmodium berghei. J Submicrosc Cytol Pathol (1998) 30(2):299–307. 
14. Pulido-Méndez M, Finol HJ, Girón ME, Aguilar I. Ultrastructural pathological 
changes in mice kidney caused by Plasmodium berghei infection. J Submicrosc 
Cytol Pathol (2006) 38(2–3):143–8. 
15. Dumont ME, Dei-Cas E, Maurois P, Slomianny C, Prensier G, Houcke-
Lecomte M, et  al. [Histopathology of the liver and kidney during malaria: 
relation to malaria-induced dyslipoproteinemia]. Ann Parasitol Hum Comp 
(1988) 63(3):171–83. 
16. Charron AJ, Sibley LD. Host cells: mobilizable lipid resources for the intracel-
lular parasite Toxoplasma gondii. J Cell Sci (2002) 115(Pt 15):3049–59. 
17. Gomes AF, Magalhaes KG, Rodrigues RM, de Carvalho L, Molinaro R, Bozza 
PT, et al. Toxoplasma gondii-skeletal muscle cells interaction increases lipid 
droplet biogenesis and positively modulates the production of IL-12, IFN-g 
and PGE2. Parasit Vectors (2014) 7:47. doi:10.1186/1756-3305-7-47 
18. Melo RCN, D’Avila H, Fabrino DL, Almeida PE, Bozza PT. Macrophage lipid 
body induction by Chagas disease in  vivo: putative intracellular domains 
for eicosanoid formation during infection. Tissue Cell (2003) 35(1):59–67. 
doi:10.1016/S0040-8166(02)00105-2 
19. Melo RCN, Fabrino DL, Dias FF, Parreira GG. Lipid bodies: structural mark-
ers of inflammatory macrophages in innate immunity. Inflamm Res (2006) 
55(8):342–8. doi:10.1007/s00011-006-5205-0 
20. D’Avila H, Freire-de-Lima CG, Roque NR, Teixeira L, Barja-Fidalgo C, Silva 
AR, et al. Host cell lipid bodies triggered by Trypanosoma cruzi infection and 
enhanced by the uptake of apoptotic cells are associated with prostaglandin E 
generation and increased parasite growth. J Infect Dis (2011) 204(6):951–61. 
doi:10.1093/infdis/jir432 
21. Fabro AE, Calzolari G. [Increase of lipids in human chagasic placentas: 
cytochemical and biochemical study]. Rev Fac Cien Med Univ Nac Cordoba 
(1990) 48(1–2):25–32. 
22. Helms JB, Kaloyanova DV, Strating JR, van Hellemond JJ, van der Schaar HM, 
Tielens AG, et al. Targeting of the hydrophobic metabolome by pathogens. 
Traffic (2015) 16(5):439–60. doi:10.1111/tra.12280 
23. Coppens I. Contribution of host lipids to Toxoplasma pathogenesis. Cell 
Microbiol (2006) 8(1):1–9. doi:10.1111/j.1462-5822.2005.00647.x 
24. Welte MA. Proteins under new management: lipid droplets deliver. Trends Cell 
Biol (2007) 17(8):363–9. doi:10.1016/j.tcb.2007.06.004 
25. Wan HC, Melo RCN, Jin Z, Dvorak AM, Weller PF. Roles and origins of 
leukocyte lipid bodies: proteomic and ultrastructural studies. FASEB J (2007) 
21(1):167–78. doi:10.1096/fj.06-6711com 
26. Melo RCN, Weller PF. Unraveling the complexity of lipid body organelles 
in human eosinophils. J Leukoc Biol (2014) 96(5):703–12. doi:10.1189/
jlb.3RU0214-110R 
27. Melo RCN, Machado CRS. Trypanosoma cruzi: peripheral blood monocytes 
and heart macrophages in the resistance to acute experimental infection in 
rats. Exp Parasitol (2001) 97(1):15–23. doi:10.1006/expr.2000.4576 
28. Melo RCN. Acute heart inflammation: ultrastructural and functional aspects 
of macrophages elicited by Trypanosoma cruzi infection. J Cell Mol Med 
(2009) 13(2):279–94. doi:10.1111/j.1582-4934.2008.00388.x 
29. D’Avila H, Melo RCN, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto 
HC, Bozza PT. Mycobacterium bovis bacillus Calmette-Guerin induces 
TLR2-mediated formation of lipid bodies: intracellular domains for eico-
sanoid synthesis in  vivo. J Immunol (2006) 176(5):3087–97. doi:10.4049/
jimmunol.176.5.3087 
30. Mattos KA, D’Avila H, Rodrigues LS, Oliveira VG, Sarno EN, Atella GC, et al. 
Lipid droplet formation in leprosy: toll-like receptor-regulated organelles 
involved in eicosanoid formation and Mycobacterium leprae pathogenesis. 
J Leukoc Biol (2010) 87(3):371–84. doi:10.1189/jlb.0609433 
6Toledo et al. Lipid Bodies and Protozoan Parasites
Frontiers in Immunology | www.frontiersin.org May 2016 | Volume 7 | Article 174
31. Mota LA, Roberto Neto J, Monteiro VG, Lobato CS, Oliveira MA, Cunha M, 
et al. Culture of mouse peritoneal macrophages with mouse serum induces 
lipid bodies that associate with the parasitophorous vacuole and decrease their 
microbicidal capacity against Toxoplasma gondii. Mem Inst Oswaldo Cruz 
(2014) 109(6):767–74. 
32. Combs TP, Nagajyothi, Mukherjee S, de Almeida CJ, Jelicks LA, 
Schubert W, et al. The adipocyte as an important target cell for Trypanosoma 
cruzi infection. J Biol Chem (2005) 280(25):24085–94. doi:10.1074/jbc.
M412802200 
33. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH. Cytoplasmic 
lipid droplets are translocated into the lumen of the Chlamydia trachomatis 
parasitophorous vacuole. Proc Natl Acad Sci U S A (2008) 105(27):9379–84. 
doi:10.1073/pnas.0712241105 
34. Dumoux M, Hayward RD. Membrane contact sites between pathogen- 
containing compartments and host organelles. Biochim Biophys Acta (2016). 
doi:10.1016/j.bbalip.2016.01.018 
35. Simoes AP, Roelofsen B, Op den Kamp JA. Incorporation of free fatty acids 
can explain alterations in the molecular species composition of phosphatidyl-
choline and phosphatidylethanolamine in human erythrocytes as induced by 
Plasmodium falciparum. Cell Biol Int Rep (1992) 16(6):533–45. doi:10.1016/
S0309-1651(05)80052-9 
36. Itoe MA, Sampaio JL, Cabal GG, Real E, Zuzarte-Luis V, March S, et al. Host 
cell phosphatidylcholine is a key mediator of malaria parasite survival during 
liver stage infection. Cell Host Microbe (2014) 16(6):778–86. doi:10.1016/j.
chom.2014.11.006 
37. Hamid PH, Hirzmann J, Kerner K, Gimpl G, Lochnit G, Hermosilla CR, 
et  al. Eimeria bovis infection modulates endothelial host cell cholesterol 
metabolism for successful replication. Vet Res (2015) 46:100. doi:10.1186/
s13567-015-0230-z 
38. Nishikawa Y, Quittnat F, Stedman TT, Voelker DR, Choi JY, Zahn 
M, et  al. Host cell lipids control cholesteryl ester synthesis and stor-
age in intracellular Toxoplasma. Cell Microbiol (2005) 7(6):849–67. 
doi:10.1111/j.1462-5822.2005.00518.x 
39. Labaied M, Jayabalasingham B, Bano N, Cha SJ, Sandoval J, Guan G, et al. 
Plasmodium salvages cholesterol internalized by LDL and synthesized de 
novo in the liver. Cell Microbiol (2011) 13(4):569–86. doi:10.1111/j.1462-5822. 
2010.01555.x 
40. Ehrenman K, Wanyiri JW, Bhat N, Ward HD, Coppens I. Cryptosporidium 
parvum scavenges LDL-derived cholesterol and micellar cholesterol 
internalized into enterocytes. Cell Microbiol (2013) 15(7):1182–97. doi:10.1111/ 
cmi.12107 
41. Jackson KE, Klonis N, Ferguson DJ, Adisa A, Dogovski C, Tilley L. Food 
vacuole-associated lipid bodies and heterogeneous lipid environments in the 
malaria parasite, Plasmodium falciparum. Mol Microbiol (2004) 54(1):109–22. 
doi:10.1111/j.1365-2958.2004.04284 
42. Caffaro CE, Boothroyd JC. Evidence for host cells as the major contributor of 
lipids in the intravacuolar network of Toxoplasma-infected cells. Eukaryot Cell 
(2011) 10(8):1095–9. doi:10.1128/EC.00002-11 
43. Hamid PH, Hirzmann J, Hermosilla C, Taubert A. Differential inhibition of 
host cell cholesterol de novo biosynthesis and processing abrogates Eimeria 
bovis intracellular development. Parasitol Res (2014) 113(11):4165–76. 
doi:10.1007/s00436-014-4092-5 
44. Sibley LD, Niesman IR, Parmley SF, Cesbron-Delauw MF. Regulated secretion 
of multi-lamellar vesicles leads to formation of a tubulo-vesicular network 
in host-cell vacuoles occupied by Toxoplasma gondii. J Cell Sci (1995) 108 
(Pt 4):1669–77. 
45. Farese RV Jr, Walther TC. Lipid droplets finally get a little R-E-S-P-E-C-T. Cell 
(2009) 139(5):855–60. doi:10.1016/j.cell.2009.11.005 
46. Wenk MR. Lipidomics of host-pathogen interactions. FEBS Lett (2006) 
580(23):5541–51. doi:10.1016/j.febslet.2006.07.007 
47. Penno A, Hackenbroich G, Thiele C. Phospholipids and lipid droplets. Biochim 
Biophys Acta (2013) 1831(3):589–94. doi:10.1016/j.bbalip.2012.12.001 
48. Tzipori S, Ward H. Cryptosporidiosis: biology, pathogenesis and disease. 
Microbes Infect (2002) 4(10):1047–58. doi:10.1016/S1286-4579(02)01629-5 
49. Melo RCN, Weller PF. Lipid droplets in leukocytes: organelles linked to 
inflammatory responses. Exp Cell Res (2016) 340(2):193–7. doi:10.1016/j.
yexcr.2015.10.028 
50. Weller PF, Dvorak AM. Arachidonic acid incorporation by cytoplasmic lipid 
bodies of human eosinophils. Blood (1985) 65(5):1269–74. 
51. Weller PF, Monahan-Earley RA, Dvorak HF, Dvorak AM. Cytoplasmic lipid 
bodies of human eosinophils. Subcellular isolation and analysis of arachido-
nate incorporation. Am J Pathol (1991) 138(1):141–8. 
52. Dvorak AM, Morgan E, Schleimer RP, Ryeom SW, Lichtenstein LM, Weller PF. 
Ultrastructural immunogold localization of prostaglandin endoperoxide syn-
thase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in 
human lung mast cells, alveolar macrophages, type II pneumocytes, and neutro-
phils. J Histochem Cytochem (1992) 40(6):759–69. doi:10.1177/40.6.1316915 
53. Dvorak AM, Morgan ES, Tzizik DM, Weller PF. Prostaglandin endoperoxide syn-
thase (cyclooxygenase): ultrastructural localization to nonmembrane-bound 
cytoplasmic lipid bodies in human eosinophils and 3T3 fibroblasts. Int Arch 
Allergy Immunol (1994) 105(3):245–50. doi:10.1159/000236764 
54. Bozza PT, Yu W, Penrose JF, Morgan ES, Dvorak AM, Weller PF. Eosinophil 
lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid 
formation. J Exp Med (1997) 186(6):909–20. doi:10.1084/jem.186.6.909 
55. Bozza PT, Yu W, Cassara J, Weller PF. Pathways for eosinophil lipid body 
induction: differing signal transduction in cells from normal and hypereosin-
ophilic subjects. J Leukoc Biol (1998) 64(4):563–9. 
56. Bandeira-Melo C, Phoofolo M, Weller PF. Extranuclear lipid bodies, elicited 
by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced 
leukotriene C4 production in eosinophils and basophils. J Biol Chem (2001) 
276(25):22779–87. doi:10.1074/jbc.M101436200 
57. Vieira-de-Abreu A, Assis EF, Gomes GS, Castro-Faria-Neto HC, Weller PF, 
Bandeira-Melo C, et al. Allergic challenge-elicited lipid bodies compartmen-
talize in vivo leukotriene C4 synthesis within eosinophils. Am J Respir Cell Mol 
Biol (2005) 33(3):254–61. doi:10.1165/rcmb.2005-0145OC 
58. Pacheco P, Vieira-de-Abreu A, Gomes RN, Barbosa-Lima G, Wermelinger LB, 
Maya-Monteiro CM, et al. Monocyte chemoattractant protein-1/CC chemokine 
ligand 2 controls microtubule-driven biogenesis and leukotriene B4-synthesizing 
function of macrophage lipid bodies elicited by innate immune response. 
J Immunol (2007) 179(12):8500–8. doi:10.4049/jimmunol.179.12.8500 
59. Bozza PT, Payne JL, Morham SG, Langenbach R, Smithies O, Weller 
PF. Leukocyte lipid body formation and eicosanoid generation: 
 cyclooxygenase-independent inhibition by aspirin. Proc Natl Acad Sci U S A 
(1996) 93(20):11091–6. doi:10.1073/pnas.93.20.11091 
60. Renz H, Gong J-H, Schmidt A, Nain M, Gemsa D. Release of tumor necrosis 
factor-alpha from macrophages. Enhancement and suppression are dose- 
dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 
(1988) 141(7):2388–93. 
61. Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but 
not of Th2 lymphokines. J Immunol (1991) 146(1):108–13. 
62. Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol 
(2012) 188(1):21–8. doi:10.4049/jimmunol.1101029 
63. Mattos KA, Oliveira VC, Berredo-Pinho M, Amaral JJ, Antunes LC, Melo 
RCN, et al. Mycobacterium leprae intracellular survival relies on cholesterol 
accumulation in infected macrophages: a potential target for new drugs for 
leprosy treatment. Cell Microbiol (2014) 16(6):797–815. doi:10.1111/cmi. 
12279 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Toledo, D’Avila and Melo. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License (CC BY). The use, 
distribution or reproduction in other forums is permitted, provided the original 
author(s) or licensor are credited and that the original publication in this journal 
is cited, in accordance with accepted academic practice. No use, distribution or 
reproduction is permitted which does not comply with these terms.
